BEUDAMED
    FDA Adverse Event Injury Summary report: N

    GLOVE

    MDR report key: 1726709 · Received June 9, 2010

    Report

    Report Number
    MW5016344
    Event Type
    Injury
    Date Received
    June 9, 2010
    Date of Event
    May 19, 2010
    Report Date
    June 9, 2010
    Product Code
    KGO
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    IL, US
    Reporter Occupation
    PHARMACIST

    Narratives

    Description of Event or Problem · 1

    NARRATIVE: PER DISCHARGE SUMMARY OF (B) (6) 2010, DISCHARGE DIAGNOSES- SWOLLEN EYES, SHORTNESS OF BREATH, GENERAL. HISTORY OF PRESENT ILLNESS- THE PT IS A (B) (6) MALE WITH A PAST MEDICAL HISTORY OF HYPERTENSION, PERIPHERAL VASCULAR DISEASE, AND ALCOHOL ABUSE, WHO WAS TRANSFERRED FROM THE OPERATING ROOM STATUS POST PROSTATE BIOPSY AFTER HAVING AN EXPOSURE TO LATEX. THE PT HAS A LATEX ALLERGY AND HAS ALLERGY PREVIOUSLY DOCUMENTED AS RUBBER ALLERGY. THE PT NOTED SYMPTOMS AFTER THE PROCEDURE WAS FINISHED AND ASKED IF THEY HAD USED LATEX, WHICH THEY HAD. THE PT BEGAN TO DEVELOP HIVES AND PERIORBITAL SWELLING. HE FELT ITCHY AND WAS TRANSFERRED TO STEPDOWN. HOSPITAL COURSE- IN THE STEPDOWN UNIT, HE WAS GIVEN DIPHENHYDRAMINE 50 MG INTRAMUSCULARLY. HE WAS ALSO STARTED ON SOLU-MEDROL 125 MG WITH ONE DOSE NOW AND EVERY EIGHT HOURS. HE WAS MONITORED OVERNIGHT AND WAS GIVEN COMPAZINE FOR NAUSEA. SYMPTOMS: DYSPNEA, PRURITUS AND VOMITING. TREATMENT DRUGS USED: METHYLPREDNISOLONE: DOSE - 125, UNITS - MG, FREQ - ONCE, ROUTE - IV. DIPHENHYDRAMINE: DOSE - 50, UNITS - MG, FREQ - ONCE, ROUTE - IM. PROCHLORPERAZINE: DOSE - 10, UNITS - MG, FREQ - ONCE, ROUTE - IM. FREQUENCY - ONCE. ROUTE: TOP. DATES OF USE: (B) (6) 2010 THRU (B) (6) 2010. EVENT ABATED AFTER USE: YES.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 GLOVE NONE KGO

    Patients

    Seq Age Sex Outcome Treatment
    1 52 YR Hospitalization METHYLPREDNISOLONE| PROCHLORPERAZINE| DIPHENHYDRAMINE